Provided by Tiger Trade Technology Pte. Ltd.

Sable Offshore Corp.

3.44
-0.0214-0.62%
Volume:1.19M
Turnover:4.10M
Market Cap:660.21M
PE:-1.02
High:3.50
Open:3.44
Low:3.39
Close:3.46
52wk High:20.74
52wk Low:2.88
Shares:192.00M
Float Shares:137.00M
Volume Ratio:0.62
T/O Rate:0.87%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-3.3799
EPS(LYR):-4.1777
ROE:-103.21%
ROA:-14.02%
PB:1.67
PE(LYR):-0.82

Loading ...

Edesa Biotech Reports Positive Exploratory Data for Paridiprubart in Patients with Acute Kidney Injury

GlobeNewswire
·
Jun 05

Top Growth Companies With Insider Ownership In June 2026

Simply Wall St.
·
Jun 05

Rezolute Announces Four Presentations at the Upcoming Annual Meeting of the Endocrine Society

GlobeNewswire
·
Jun 04

Jefferies Remains a Buy on Sable Offshore (SOC)

TIPRANKS
·
Jun 03

Gerdes Energy Research downgrades Sable Offshore (SOC) to a Hold

TIPRANKS
·
Jun 03

U.S. RESEARCH ROUNDUP-Edgewise Therapeutics, IBM, Rubrik

Reuters
·
Jun 02

Sable Offshore Corp : Gerdes Energy Research Cuts to Neutral From Buy; Cuts Target Price by $4 to $13

THOMSON REUTERS
·
Jun 02

Trump secretaries to visit Sable Offshore, Politico reports

TIPRANKS
·
Jun 02

Sable Offshore price target lowered to $22 from $24 at Roth Capital

TIPRANKS
·
Jun 02

Sable Offshore says Platform Hondo expected to come online in Q3

TIPRANKS
·
Jun 02

UCB and Biogen Announce Publication in The Lancet of Positive Dapirolizumab Pegol (DZP) Phase 3 Study Results in Systemic Lupus Erythematosus

GlobeNewswire
·
Jun 01

District court denies California parks department bid to block Sable Offshore pipeline

Reuters
·
May 29

Systemic immune activation with eftilagimod alfa associated with statistically significant increased overall survival in late-stage cancer patients

GlobeNewswire
·
May 28

Sable Offshore Corp put volume heavy and directionally bearish

TIPRANKS
·
May 27

Genmab to Highlight Advances Across Its Oncology Portfolio at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting and the European Hematology Association (EHA) 2026 Congress

GlobeNewswire
·
May 22

How Investors Are Reacting To Sable Offshore (SOC) Deeper Losses And High‑Risk Offshore Restart Strategy

Simply Wall St.
·
May 15

GRI Bio Reports First Quarter 2026 Financial Results, New Data Reinforcing Differentiated Profile of GRI-0621 in Idiopathic Pulmonary Fibrosis and Highlights Continued Advancement of Differentiated Immune-Modulating Pipeline

GlobeNewswire
·
May 14

MEDIPOST's CARTISTEM® Meets All Primary and Secondary Endpoints in Japan Phase 3 Trial and Demonstrates Statistically Significant Efficacy Gains Versus Active Control

prnewswire
·
May 14

Press Release: Sionna Therapeutics Reports First Quarter 2026 Financial Results

Dow Jones
·
May 12

Emerging Growth Status at Sable Offshore Corp. Raises Transparency and Valuation Concerns

TIPRANKS
·
May 08